ArticleBlood2006

Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors.

Meili Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.